These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6319575)

  • 21. Morphology of oligodendrocytes during demyelination in optic nerves of mice infected with Semliki Forest virus.
    Butt AM; Tutton MG; Kirvell SL; Amor S; Jenkins HG
    Neuropathol Appl Neurobiol; 1996 Dec; 22(6):540-7. PubMed ID: 9004245
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Demyelination in mice resulting from infection with a mutant of Semliki Forest virus.
    Sheahan BJ; Barrett PN; Atkins GJ
    Acta Neuropathol; 1981; 53(2):129-36. PubMed ID: 6259872
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Demyelination induced in mice by avirulent Semliki Forest virus. I. Virology and effects on optic nerve.
    Illavia SJ; Webb HE; Pathak S
    Neuropathol Appl Neurobiol; 1982; 8(1):35-42. PubMed ID: 6280088
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibody response to spike protein vaccines prepared from Semliki Forest virus.
    Balcarova J; Helenius A; Simons K
    J Gen Virol; 1981 Mar; 53(Pt 1):85-92. PubMed ID: 6268742
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In Semliki Forest virus encephalitis, antibody rapidly clears infectious virus and is required to eliminate viral material from the brain, but is not required to generate lesions of demyelination.
    Fragkoudis R; Ballany CM; Boyd A; Fazakerley JK
    J Gen Virol; 2008 Oct; 89(Pt 10):2565-2568. PubMed ID: 18796725
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Semliki Forest virus-induced demyelination and remyelination--involvement of B cells and anti-myelin antibodies.
    Mokhtarian F; Huan CM; Roman C; Raine CS
    J Neuroimmunol; 2003 Apr; 137(1-2):19-31. PubMed ID: 12667644
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Virulent and avirulent strains of Semliki Forest virus show similar cell tropism for the murine central nervous system but differ in the severity and rate of induction of cytolytic damage.
    Balluz IM; Glasgow GM; Killen HM; Mabruk MJ; Sheahan BJ; Atkins GJ
    Neuropathol Appl Neurobiol; 1993 Jun; 19(3):233-9. PubMed ID: 8395026
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of mouse strain on the pathogenesis of the encephalitis and demyelination induced by avirulent Semliki Forest virus infections.
    Suckling AJ; Jagelman S; Illavia SJ; Webb HE
    Br J Exp Pathol; 1980 Jun; 61(3):281-4. PubMed ID: 6252935
    [TBL] [Abstract][Full Text] [Related]  

  • 29. B cells and antibodies in the pathogenesis of myelin injury in Semliki Forest Virus encephalomyelitis.
    Smith-Norowitz TA; Sobel RA; Mokhtarian F
    Cell Immunol; 2000 Feb; 200(1):27-35. PubMed ID: 10716880
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of cycloleucine on SFV A7(74) infection in mice.
    Amor S; Webb HE
    Br J Exp Pathol; 1987 Apr; 68(2):225-35. PubMed ID: 3034321
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Persistence of virulent Semliki Forest virus in mouse brain following co-inoculation with defective interfering particles.
    Atkinson T; Barrett AD; Mackenzie A; Dimmock NJ
    J Gen Virol; 1986 Jun; 67 ( Pt 6)():1189-94. PubMed ID: 3011976
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of γδ T cells in antibody production and recovery from SFV demyelinating disease.
    Safavi F; Feliberti JP; Raine CS; Mokhtarian F
    J Neuroimmunol; 2011 Jun; 235(1-2):18-26. PubMed ID: 21612829
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term effects of Semliki Forest virus infection in the mouse central nervous system.
    Donnelly SM; Sheahan BJ; Atkins GJ
    Neuropathol Appl Neurobiol; 1997 Jun; 23(3):235-41. PubMed ID: 9223133
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation of Semliki Forest virus-induced infection of mice by defective-interfering virus.
    Barrett AD; Dimmock NJ
    J Infect Dis; 1984 Jul; 150(1):98-104. PubMed ID: 6086774
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo depletion of CD8+ T cells prevents lesions of demyelination in Semliki Forest virus infection.
    Subak-Sharpe I; Dyson H; Fazakerley J
    J Virol; 1993 Dec; 67(12):7629-33. PubMed ID: 7901429
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Isolation and preliminary characterization of Semliki Forest virus mutants with altered pathogenicity for mouse embryos.
    Hearne AM; O'Sullivan MA; Atkins GJ
    J Gen Virol; 1987 Jan; 68 ( Pt 1)():107-13. PubMed ID: 3027238
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predisposition to EAE induction in resistant mice by prior infection with Semliki Forest virus.
    Mokhtarian F; Swoveland P
    J Immunol; 1987 May; 138(10):3264-8. PubMed ID: 2437186
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of complement in monoclonal antibody-mediated protection against virulent Semliki Forest virus.
    Boere WA; Benaissa-Trouw BJ; Harmsen T; Erich T; Kraaijeveld CA; Snippe H
    Immunology; 1986 Aug; 58(4):553-9. PubMed ID: 3015781
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Virus-associated demyelination. A model using avirulent Semliki Forest virus infection of mice.
    Suckling AJ; Pathak S; Jagelman S; Webb HE
    J Neurol Sci; 1978 Nov; 39(1):147-54. PubMed ID: 731269
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CNS pathogenesis following a dual viral infection with Semliki Forest (alphavirus) and Langat (flavivirus).
    Amor S; Webb HE
    Br J Exp Pathol; 1988 Apr; 69(2):197-208. PubMed ID: 2837265
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.